Enzychem Lifesciences Corp

183490

Company Profile

  • Business description

    Enzychem Lifesciences Corp develops and produces APIs and functional health foods. The company's business divisions are divided into the Global New Drug Development, Pharmaceutical Active Ingredients, and Health Functional Foods divisions, as well as the Bio-oil (HVO raw materials, SAF raw materials) business division of its subsidiary. The products of the company include erdosteine (cough suppressant/expectorant), gadobutrol (contrast agent), D-cycloserine (anti-tuberculosis agent), sarpogrelate (anticoagulant), zinc carnosine (anti-ulcer agent), and zaltoprofen (anti-inflammatory analgesic), and others.

  • Contact

    59, Biovalley-ro
    Wangam-dong
    Jecheon-siChungcheongbuk-do135-280
    KOR

    T: +82 436522845

    https://www.enzychem.co.kr

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2026

    Employees

    130

Stocks News & Analysis

stocks

Wide moat share expects luck to turn

A tough year for jackpots however earnings are expected to normalise.
stocks

ASX share’s growth story intact despite supply constraints

Short term supply challenges but Chinese growth story remains intact.
stocks

ASX healthcare giant rallies despite a fall in profits

Easing investor concerns and signalling a return to growth.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,269.7013.70-0.15%
CAC 408,475.6622.570.27%
DAX 4026,090.51107.470.41%
Dow JONES (US)52,759.21703.84-1.32%
FTSE 10010,779.3531.190.29%
HKSE26,009.46310.971.21%
NASDAQ26,067.17263.92-1.00%
Nikkei 22566,016.36200.43-0.30%
NZX 50 Index13,972.6652.840.38%
S&P 5007,641.160.000.00%
S&P/ASX 2009,058.906.90-0.08%
SSE Composite Index3,905.201.480.04%

Market Movers